 
 
EXPLANATION:  CAPITALS INDICATE MAT TER ADDED TO EXISTIN G LAW . 
        [Brackets ] indicate matter deleted from existing law.  
         Underlining  indicates amendments to bill.  
         Strike out  indicates matter stricken from the bill by amendment or deleted from the law by 
amendment.             *hb1007*      
HOUSE BILL 1007  
C4, J1    5lr2658  
HB 982/24 – HGO    CF SB 757  
By: Delegate Wells  Delegates Wells, Alston, Bagnall , Bhandari, Chisholm, 
Cullison, Guzzone, Hill, Hutchinson, S.  Johnson, Kaiser, Kerr, Kipke, 
Lopez, Martinez, M.  Morgan, Pena –Melnyk, Reilly, Rosenberg, Ross, 
Szeliga, Taveras, White  Holland, Woods, and Woorman  
Introduced and read first time: January 31, 2025  
Assigned to: Health and Government Operations  
Committee Report: Favorable with amendments  
House action: Adopted  
Read second time: March 6, 2025  
 
CHAPTER ______  
 
AN ACT concerning  1 
 
Genetic Testing – Prohibition on Disability, Life, and Long –Term Care 2 
Insurance   3 
Disability and Life Insurance – Medical Information  4 
(Genetic Testing Protection Act)  5 
 
FOR the purpose of prohibiting insurance carriers that offer life insurance , long–term care 6 
insurance,  or disability insurance policies or contracts from taking certain actions 7 
relating to coverage based on whether an applicant or a policy or contract holder has 8 
requested or undergone genetic testing or the results of the genetic testing;  unfairly 9 
discrimi nating against an individual by taking certain actions relating to coverage 10 
based on medical information; prohibiting certain carriers from accessing sensitive 11 
medical information without first obtaining written consent or mandating certain 12 
genetic testing  or full genome sequencing for a certain purpose;  and generally 13 
relating to genetic testing  life and disability insurance . 14 
 
BY adding to  15 
 Article – Insurance  16 
Section 27 –909.1  17 
 Annotated Code of Maryland  18 
 (2017 Replacement Volume and 2024 Supplement)  19 
 
2 HOUSE BILL 1007   
 
  SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 1 
That the Laws of Maryland read as follows:  2 
 
Article – Insurance  3 
 
27–909.1.  4 
 
 (A) (1) IN THIS SECTION THE F OLLOWING WORDS HAVE THE MEANINGS 5 
INDICATED . 6 
 
  (2) “GENE PRODUCT ” MEANS THE BIOCHEMICA L MATERIAL , EITHER  7 
RNA  OR PROTEIN , MADE BY A GENE . 8 
 
  (3) (I) “GENETIC INFORMATION ” MEANS INFORMATION : 9 
 
    1. DERIVED FROM A GENET IC TEST ABOUT  10 
CHROMOSOMES , GENES , OR GENE PRODUCTS THA T MAY DERIVE FROM AN  11 
INDIVIDUAL OR A FAMI LY MEMBER ; 12 
 
    2. NOT OBTAINED FOR DIAGNOSTIC OR TH ERAPEUTIC  13 
PURPOSES ; AND  14 
 
    3. OBTAINED AT A TIME W HEN THE INDIVIDUAL T O 15 
WHOM THE INFORMATION  RELATES IS ASYMPTOMA TIC FOR THE DISEASE , 16 
DISORDER , ILLNESS , OR IMPAIRMENT TO WHI CH THE INFORMATION R ELATES .  17 
 
   (II) “GENETIC INFORMATION ” DOES NOT INCLUDE : 18 
 
    1. ROUTINE PHYSICAL MEA SUREMENTS ; 19 
 
    2. CHEMICAL , BLOOD , AND URINE ANALYSES T HAT ARE  20 
WIDELY ACCEPTED AND IN USE IN CLINICAL P RACTICE ;  21 
 
    3. TESTS FOR USE OF DRU GS;  22 
 
    4. TESTS FOR THE PRESEN CE OF THE HUMAN  23 
IMMUNODEFICIENCY VIRUS ; OR 24 
 
    5. FAMILY MEDICAL HISTO RY, EXCEPT FOR FAMILY  25 
GENETICS AS THEY REL ATE TO A GENETIC TES T DESCRIBED IN SUBPA RAGRAPH (I)1 26 
OF THIS PARAGRAPH . 27 
 
  (4) “GENETIC SERVICES ” MEANS HEALTH SERVICE S THAT ARE  28 
PROVIDED TO OBTAIN , ASSESS , OR INTERPRET GENETI C INFORMATION OR THE  29 
RESULTS OF GENETIC T ESTS .  30 
 HOUSE BILL 1007  3 
 
  
  (5) (2) “GENETIC TEST ” MEANS AN ANALYSIS OF  HUMAN DNA,  1 
RNA,  CHROMOSOMES , PROTEINS , OR METABOLITES THAT DETECTS GENOTYPES , 2 
MUTATIONS , OR CHROMOSOMAL CHANG ES. 3 
 
  (6) (3) “INSURANCE CARRIER ” MEANS A COMPANY AUTHORIZED 4 
TO SELL INSURANCE PO LICIES IN THE STATE . 5 
 
 (B) (1) THIS SECTION APPLIES ONLY TO LIFE INSURAN CE, LONG–TERM  6 
CARE INSURANCE , AND DISABILITY INSUR ANCE POLICIES OR CON TRACTS . 7 
 
  (2) THIS SECTION DOES NOT  PROHIBIT AN INSURANC E CARRIER THAT 8 
OFFERS , ISSUES , OR DELIVERS A LIFE I NSURANCE , LONG–TERM CARE INSURANCE , 9 
OR DISABILITY INSURA NCE POLICY OR CONTRA CT IN THE STATE FROM : 10 
 
   (I) ACCESSING AN APPLICA NT’S MEDICAL RECORD AS PART OF 11 
THE APPLICATION PROC ESS; OR 12 
 
   (II) CONSIDERING A MEDICA L DIAGNOSIS IN CLUDED IN AN 13 
INDIVIDUAL ’S MEDICAL RECORD , EVEN IF THE DIAGNOSI S WAS BASED ON THE 14 
RESULTS OF A GENETIC  TEST . 15 
 
 (C) (1) AN EXCEPT AS PROVIDED IN  PARAGRAPH (2) OF THIS 16 
SUBSECTION AND SUBJE CT TO PARAGRAPH (3) OF THIS SUBSECTION , AN 17 
INSURANCE CARRIER TH AT OFFER S, ISSUES , OR DELIVERS A LIFE I NSURANCE , 18 
LONG–TERM CARE INSURANCE , OR DISABILITY INSURA NCE POLICY OR CONTRA CT IN 19 
THE STATE MAY NOT : UNFAIRLY DISCRIMINAT E AGAINST AN INDIVID UAL BY 20 
CONDITIONING INSURAN CE RATES , THE PROVISION OR REN EWAL OF INSURANCE 21 
COVERAGE , OR OTHER CONDITIONS OF INSURANCE BASED O N MEDICAL 22 
INFORMATION , INCLUDING THE RESULT S OF A GENETIC TEST FOR WHICH THERE IS 23 
NOT A RELATIONSHIP B ETWEEN THE MEDICAL I NFORMATION AND THE C OST OF THE 24 
INSURANCE RISK THAT THE INSURER WOULD AS SUME BY INSURING THE  APPLICANT .  25 
 
  (2) IN DEMONSTRATING THE RELATIONSHIP DESCRIB ED IN 26 
PARAGRAPH (1) OF THIS SUBSECTION , THE INSURER MAY RELY  ON ACTUARIALLY 27 
SOUND PRINCIPLES OR ACTUAL OR REASONABLY  ANTICIPATED EXPERIEN CE. 28 
 
  (3) AN INSURANCE CARRIER THAT OFFERS , ISSUES , OR DELI VERS A 29 
LIFE INSURANCE OR DI SABILITY INSURANCE P OLICY OR CONTRACT IN  THE STATE 30 
MAY NOT : 31 
 
   (I) ACCESS SENSITIVE MED ICAL INFORMATION , INCLUDING 32 
THE GENETIC DATA OF AN INDIVIDUAL , WITHOUT FIRST OBTAIN ING THE 33 
INDIVIDUAL ’S SIGNED , WRITTEN CONSENT ; OR 34 
4 HOUSE BILL 1007   
 
  
   (II) MANDATE EXISTING OR NEW GENETIC TESTING OR FULL 1 
GENOME SEQUENCING AS  A PREREQUISITE FOR L IFE INSURANCE OR DIS ABILITY 2 
INSURANCE ELIGIBILIT Y OR COVERAGE .  3 
 
   (I) DENY OR LIMIT COVERA GE BASED ON WHETHER AN 4 
APPLICANT OR A POLIC Y OR CONTRACT HOLDER  HAS UNDERGO NE A GENETIC TEST ; 5 
 
   (II) PROHIBIT , AS A CONDITION OF CO NTINUING COVERAGE , A 6 
POLICY OR CONTRACT H OLDER FROM UNDERGOIN G A GENETIC TEST ; OR 7 
 
   (III) USE A GENETIC TEST , THE RESULTS OF A GEN ETIC TEST , 8 
GENETIC INFORMATION , OR A REQUEST FOR GEN ETIC SERVICES TO REJECT , DENY , 9 
LIMIT , CANCEL , REFUSE TO RENEW , INCREASE THE RATES O F, AFFECT THE TERMS  10 
OR CONDITIONS OF , OR OTHERWISE AFFECT A LIFE INSURANCE , LONG–TERM CARE  11 
INSURANCE , OR DISABILITY INSURA NCE POLICY OR CONTRA CT. 12 
 
  (2) (4) THE INSURANCE CARRIER , APPLICANT , OR POLICY OR 13 
CONTRACT HOLDER MAY NOT CHANGE , WAIVE , DISCHARGE , OR TERMINATE  THE 14 
PROVISIONS OF PARAGR APH (1) (3)( II) OF THIS SUBSECTION U NDER ANY 15 
CIRCUMSTANCES . 16 
 
 (D) THE COMMISSIONER MAY ISSU E AN ORDER UNDER §§ 4–113 AND 4–114 17 
OF THIS ARTICLE OR §§ 27–501 AND 27–505 OF THIS TITLE IF THE  COMMISSIONER 18 
FINDS A VIOLATION OF  THIS SECTION .  19 
 
 SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect 20 
October 1, 2025.  21 
 
 
 
 
Approved:  
________________________________ ________________________________ ________________   
           Governor.  
________________________________ ________________________________ ________________   
         Speaker of the House of Delegates.  
________________________________ ________________________________ ________________   
                 President of the Senate.  